Search tips
Search criteria 


Logo of schbulschizophrenia bulletinsubscriptionscontact uscurrent issuemy basketarchivemy accountsearchcontact this journaloxford journalsabout this journal
Schizophr Bull. 2007 January; 33(1): 192–199.
Published online 2006 August 7. doi:  10.1093/schbul/sbl016
PMCID: PMC2012366

Toward Understanding the Insight Paradox: Internalized Stigma Moderates the Association Between Insight and Social Functioning, Hope, and Self-esteem Among People with Schizophrenia Spectrum Disorders


Research has paradoxically linked awareness of illness to both better function outcomes and lesser hope and self-esteem. One possible explanation for these findings is that acceptance of having schizophrenia may impact outcomes differently depending on the meanings the person attaches to this acceptance, particularly whether he or she accepts stigmatizing beliefs about mental illness. To explore this possibility we performed a cluster analysis of 75 persons with schizophrenia spectrum disorders based on single measures of insight using the Positive and Negative Syndrome Scale, internalized stigma using the Internalized Stigma of Mental Illness Scale, and compared groups on concurrent assessments of hope and self-esteem. Three groups were produced by the cluster analyses: low in sight/mild stigma (n = 23), high insight/minimal stigma (n = 25), and high insight/moderate stigma (n = 27). As predicted, analysis of variance–comparing groups revealed that the high insight/moderate stigma group had significantly the lowest levels of hope on the Beck Hopelessness Scale and self-esteem using the Multidimensional Self-esteem Inventory. As predicted, the high insight/minimal stigma group also had significantly less impaired social function than the other groups. Implications for assisting persons to come to cope with awareness of illness and stigma are discussed.

Keywords: schizophrenia, stigma, quality of life, insight, hope, social function, narrative

Relative to persons with other psychiatric disorders, persons with schizophrenia spectrum disorders are often unaware or willfully contest that they have what others think to be a mental illness.1,2 Taken as a whole, this phenomenon, often referred to as “lack of awareness” or “poor insight,” has shown a pattern of apparently contradictory associations with outcome. For instance, poor insight has been linked to poorer treatment adherence,3,4 poorer clinical outcome,5 poorer social function,68 vocational dysfunction,9 and difficulties developing working relationships with mental health professionals.10 On the other hand, greater insight has been associated with higher levels of dysphoria,1114 lowered self-esteem,15 and decreased well-being and quality of life.1621

One possible explanation for the seemingly contradictory findings is that the impact of the acceptance of schizophrenia depends on the meanings persons attach to schizophrenia.22 For example, if one believes the illness means that he or she is not capable of achieving valued social roles, then awareness could lead to hopelessness and less motivation to persevere. However, if one does not believe that this illness precludes chances for a satisfying life, then awareness of the illness may be a key part of negotiating the challenges posed by the symptoms and diagnostic label. Supporting this view is research suggesting “role engulfment,” or the extent to which a person adopts the identity of a “mental patient,”23 is associated with both better insight24 and poorer social functioning.25 Internalized stigma,26 a related construct reflecting the degree to which a person has internalized societally endorsed stigmatizing beliefs about mental illness (eg, people with mental illness are violent and unable to function independently), has been found to take on personal relevance when a person is diagnosed with mental illness27 and has been linked to depressed mood.26 Also consistent with this is a longitudinal qualitative study that reported that the transformation of “sense of self” from one of “patienthood” to “personhood” was an important element in the process of improving functioning in a group with severe mental illness.28

While these findings support the view that the meanings a person attaches to having a mental illness can have important implications for how awareness impacts outcomes, stigma's impact on the effects of insight on outcome in schizophrenia has yet to be explicitly studied. To investigate this we have sought to determine whether we could distinguish groups of persons with schizophrenia who varied according to level of insight and internalized stigma and then to see whether these different groups differed in hopefulness, self-esteem, and social function. Social functioning includes a person's capacity for social relations and the breadth of social relations and is a major outcome of interest for people with schizophrenia.29 Hopefulness has been found to predict problem-oriented coping when accompanied by insight30 and is by matter of definition an appraisal of the future and thus a context in which persons make decisions about how to pursue life goals. Self-esteem has been found to predict life satisfaction and is related to positive outcome among people with schizophrenia.3133

Accordingly, we made 3 hypotheses. We first predicted that clustering participants in a treatment sample by insight and internalized stigma would result in 3 groups: (a) those who held stigmatizing beliefs about mental illness and believed they had a mental illness; (b) those who did not endorse having internalized stigmatizing beliefs about mental illness and believed they had a mental illness; and (c) those who endorsed stigmatizing beliefs about mental illness but did not have insight or were not aware of their mental illness. As illustrated in figure 1, we secondly predicted that the group that rejected stigma but acknowledged their illness and the group that accepted stigma but rejected their illness would have more hope and self-esteem than the group that accepted stigma and acknowledged their illness. Third, as also illustrated in figure 1, we predicted that the group that rejected stigma and acknowledged their illness would have the best social function of all 3 groups. Here we reasoned that the lesser hope and self-esteem of the group that held stigmatizing beliefs about mental illness and believed they had a mental illness could erode social function just as the unawareness of illness in the third group could erode social function by virtue of its limiting that group's adaptation to illness. We finally planned to compare groups on symptom levels for exploratory purposes.

Fig. 1
The interactions of stigma and insight and their relationship to hope, self-esteem, and social function.



Sixty-four men and 11 women with Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (SCID34)-confirmed DSM-IV diagnoses of schizophrenia (n = 40) or schizoaffective disorder (n = 35) were recruited from a comprehensive day hospital at a VA Medical Center (n = 55) and local Community Mental Health Center (CMHC; n = 20) for a larger survey of the prevalence of anxiety symptoms in schizophrenia. All participants were receiving ongoing outpatient treatment and were in a postacute or stable phase of their disorder, defined as no hospitalizations or changes in medication or housing in the last month. Participants with a history of mental retardation documented in a chart review were excluded. Participants had a mean age of 48.25 years (SD = 7.01), a mean educational level of 12.57 (SD = 2.05), and a mean of 8.73 (SD = 9.04) lifetime hospitalizations with the first occurring on average at the age of 25.26 years (SD = 8.37). Thirty-six participants were Caucasian, 37 African American, and 2 Latino.

Participants were recruited through contact with primary providers who informed patients whom they believed met study criteria. Of those 86 participants who consented to participate, 11 completed only portions of the assessments and failed to attend follow-up appointments to complete the assessments. It is estimated that the total possible number of persons who could have been recruited was approximately 450 (300 patients in the VA and 150 in the CMHC).


The Positive and Negative Syndrome Scale (PANSS35) is a 30-item rating scale completed by clinically trained research staff at the conclusion of chart review and a semistructured interview. For the purposes of this study, 2 of the 5 PANSS factor analytically derived components36 were used: positive symptoms, which includes symptoms such as hallucinations and delusions, and negative symptoms, which includes symptoms such as lack of affect. We also included the PANSS insight and judgment item that provides a rating of 1 to 7 which reflects global awareness of symptoms, treatment need, and consequences of illness. Assessment of interrater reliability for this study was found to be high to excellent with intraclass correlations for blind raters observing the same interview ranging from .84 to .93.

The Quality of Life Scale (QOLS3,7) is a 21-item scale completed by clinically trained research staff following a semistructured interview and chart review. For the purposes of this study, we were interested in 2 of the 4 factor scores of the QOLS that are most intimately tied to social function. The first, “interpersonal relations,” measures the frequency of recent social contacts and includes separate assessments, for example, of frequency of contacts with friends and acquaintances. The second, “intrapsychic foundations,” measures qualitative aspects of interpersonal relationships and includes assessments, for example, of empathy for others. High to excellent interrater reliability was found for the 2 QOLS factor scores for this study, with intraclass correlations for blind raters observing the same interview ranging from .85 to .93. Although originally created to assess negative symptoms in schizophrenia, the QOLS has been widely used to study social function in this population.7

The Internalized Stigma of Mental Illness Scale (ISMIS26,38) is a 29-item paper and pencil questionnaire designed to assess subjective experience of stigma. It presents participants with first-person statements and asks them to rate on a 4-point Likert scale regarding whether they “Strongly disagree,” “Disagree,” “Agree,” or “Strongly agree” with statements related to having a mental illness. Items are summed to provide 4 major scale scores: alienation, which reflects feeling devalued as a member of society; stereotype endorsement, which reflects agreement with negative stereotypes of mental illness; discrimination experience, which reflects current mistreatment attributed to the biases of others; and social withdrawal, which reflects avoidance of others because of mental illness. The fifth additional score, stigma resistance, asks about participant's perceived ability to deflect stigma. All scales scores are calculated as averages with higher scores suggesting graver experiences of stigma. Evidence of acceptable internal consistency, test-retest reliability, factorial, and convergent validity have been reported, including links with morale and well-being.26,38 The instrument was presented to persons in its written form with research assistants available to assist if participants were confused about the meaning of any item.

Of note, items of ISMIS differ from the QOLS and PANSS assessments of social function detailed above because they involve explicit attributions of abstract states of impoverished function due to discrimination on the basis of mental illness or acceptance that mental illness renders persons to a lesser status. The QOLS, for instance, asks how often a person socialized with a close friend and the PANSS may involve asking a person about the absence or presence of interest in others. The ISMIS, on the other hand, asks if the person socializes less “because my mental illness might make me look or behave weird” and whether they believe in general that “Mentally ill persons should not get married.” Items of the ISMIS also differ from the PANSS assessments of difficulties trusting people or accepting as true conspiracies again them; the ISMIS asks whether the person feels discriminated against “because I have a mental illness” or whether they “feel out of place in the world because I have a mental illness.”

The Multidimensional Self-esteem Inventory (MSEI39) is a 116-item self-report measure that assesses individuals’ self-perception of their overall social value. Respondents rate items on a 5-point scale according to the degree or frequency with which each item applies to them. The MSEI offers t scores based on a community sample. The t scores are normalized scores with a mean of 50 and a standard deviation of 10. The mean t score for this sample was 44.56 with a standard deviation of 10.33. This suggests that participants’ reported level of self-esteem was approximately 0.5 standard deviations lower than those of persons in a broad community sample. Because the MSEI has been largely used in samples of persons without psychosis, internal consistency was examined in this sample. Examination of items comprising the total score revealed a highly significant degree of internal consistency (coefficient α = .90).

The Beck Hopelessness Scale40 is a 20-item questionnaire that asks participants to endorse statements as true or false as applied to them. Individual items are then summed to provide an overall index of hope or its absence. Examples of items include, respectively, “Things just won't work out the way I want them to” and “I might as well give up because I can't make things better for myself.” This scale has been used successfully with a wide range of psychiatric, medical, and community populations.41


All procedures were approved by the research review committees of Indiana University and the Roudebush VA Medical Center. Following informed consent, diagnoses were determined using the SCID conducted by a clinical psychologist. Following the SCID, participants were administered the PANSS and QOLS interviews, MSEI, and ISMIS. A research assistant was available to assist participants if there were difficulties reading or understanding the questionnaires. PANSS and QOLS ratings were performed blind to responses to the MSEI and ISMI. QOLS and PANSS interviews were conducted by trained research assistants with a minimum of a BA degree in a field related to psychology.


Means and standard deviations for all measures are presented in table 1. Analyses were conceived as the following 4 steps: First, to determine whether the first 4 subscales of the ISMIS (alienation, stereotype endorsement, discrimination experience, and social withdrawal) could be combined into a total score for the purposes of using it in a cluster analyses, internal consistency was determined. This revealed a high degree of internal consistency, coefficient α = .86, which was reduced to .80 if the fifth score was included. Correlations among all 5 ISMIS scores revealed that the first 4 scores were all significantly related to one another (P < .05), while the fifth, stigma resistance, was significantly correlated only with stereotype endorsement. These findings were taken as support to not include the fifth score in the summary score.

Table 1
Mean and Standard Deviations

In the second phase of analyses, insight and stigma scores were separately correlated with symptoms, social function, hope, and self-esteem. These revealed that internalized stigma was significantly related (P < .05) to positive (r = .36) and negative (r = .26) symptoms, as well as hope (r = −.45), self-esteem (r = .54), and QOLS interpersonal relations (r = −.34). Insight was related to positive (r = .24) and negative (r = .29) symptoms, as well as self-esteem (r = .26).

In the third phase, ISMIS and PANSS insight and judgment items were standardized into z scores and a K-Means cluster analysis was performed to identify 3 homogenous participant groups based on these scores. Cluster analysis is a method of classifying people into typologies by determining clusters of participants that display small within-cluster variation relative to the between-cluster variation.4244 In cluster analysis, each participant is assigned to a cluster and participants are moved from one cluster to another until terminating conditions are met. In essence, a cluster analysis is similar in some respects to both factor analysis and discriminant function analysis. It differs primarily from factor analysis in that its end is the determination of orthogonal groups of participants rather than orthogonal groups of variables, and it differs from a discriminant function analysis in that determining group assignment is the goal and not known ahead of time.

K-Means cluster analysis is a nonhierarchical form of cluster analysis appropriate when hypotheses exist regarding the number of clusters contained in a sample. It produces the number of clusters as initially called for, minimizing variability within clusters and maximizing variability between clusters. We chose this procedure rather than rationally defining groups in order to determine, in an exploratory and statistical manner, whether we could detect participants who demonstrated patterns of these scores as hypothesized rather than as we had artificially defined them ahead of time. To give the groups contextual meaning, however, we assigned labels with reference to the meaning of the insight and stigma scores. First, we chose to categorize groups as “low insight” if the PANSS insight item was equal or greater than 4 of 7 and scores of less then 4 as good insight. This categorization has been used elsewhere30 and reflects the difference between general vs minimal awareness that something is wrong. To describe a group's stigma level, we decided that groups with scores of 2 or less would be labeled as “minimal stigma” because such scores indicate general disagreement with items. Scores of greater than 2 but less than 2.5 were chosen to be labeled as “mild stigma,” as these scores reflect agreement of roughly less than half of the ISMIS items. Scores of greater than 2.5 but less than 3 were chosen to be labeled as “moderate stigma” because these scores reflect either agreement of more than half of ISMIS items or strong agreement on several. Scores of greater than 3 were chosen to be labeled as “severe stigma” as these scores reflect either agreement with all ISMIS items or strong agreement on many items.

The cluster analysis produced 3 groups which, based on insight and stigma levels, we have labeled low insight/mild stigma (n = 23), high insight/minimal stigma (n = 25), and high insight/moderate stigma (n = 27). As revealed in table 2, these groups did not differ significantly in age, education, or hospitalization history. Chi-square analyses additionally found that groups did not differ in proportion of participants with schizoaffective disorder or schizophrenia or in proportion of participants from the VA medical center or the CMHC. Analysis of variance also found no significant differences in raw stigma or insight score for participants from the VA medical center compared with the participants from the CMHC. Examination of symptoms, however, found that the high insight/minimal stigma group had significantly lower levels of positive and negative symptoms on the PANSS.

Table 2
Background and Symptoms Among Groups

In the third phase of analyses we compared hope, self-esteem, and social function between groups. As revealed in table 3, the high insight/minimal stigma group had significantly better interpersonal function on the QOLS than either of the other 2 groups. The high insight/moderate stigma group, by contrast, reported significantly poorer self-esteem and lesser hope than either of the other 2 groups. Given that the groups differed significantly on positive and negative symptoms, analyses comparing social function, hope, and self-esteem were repeated with positive and negative symptom scores included as covariates. In these analyses the groups continued to differ on hope and self-esteem (F2,68 = 4.72, P < .05; F2,68 = 9.35, P < .001), with the high insight/moderate stigma group again in post hoc comparisons having significantly poorer hope and self-esteem. When symptoms were statistically controlled for, however, no significant differences were found between groups on the QOLS interpersonal relations scores (F2,62 = 0.53, P = NS).

Table 3
Hope, Self-esteem, Symptoms, and Social Function Among Groups


In the current study we examined the hypothesis that the effects of awareness of illness in schizophrenia on self-esteem, hope, and functioning would be affected by the degree to which persons internalize stigmatizing views about mental illness. As predicted, a cluster analysis of persons in a stable phase of illness revealed 2 groups of persons relatively aware of having a mental illness: one group that did and another that did not endorse having self-stigmatizing beliefs about their condition. Also, as predicted, persons with high insight who endorsed self-stigmatizing beliefs had lower levels of self-esteem and hope and fewer interpersonal relationships than those with high insight who rejected stigmatizing beliefs. Finally, as predicted, the cluster analyses produced a third group that demonstrated low awareness and also endorsed stigmatizing beliefs, though to a lesser degree than did the high insight/moderate stigma group. This group also had more self-esteem and hope than the group with high insight and moderate stigma but did not differ from them in social functioning. This last finding may suggest that both the acceptance of stigma or unawareness of illness may lead to social isolation. However, it is also possible that an underlying risk factor for both poor insight and social isolation, such as neurocognitive impairment,9 may explain these relationships.

Exploratory comparisons of symptom levels between the groups revealed that groups with higher insight and minimal stigma had significantly lower levels of positive and negative symptoms than either of the 2 other groups. This suggests several possible interpretations. First, it is possible that having more symptoms makes one the target of more stigma and therefore makes it more difficult to reject these beliefs. Second, it is possible that with more symptoms it becomes harder to formulate positive beliefs about oneself and, therefore, to reject societal beliefs about schizophrenia. It is also possible that having less internalized stigma allows one to manage symptoms more effectively, thereby reducing their severity. Regardless of which interpretation is valid, when symptoms were controlled for, groups continued to differ on self-esteem and hope, although notably group differences in interpersonal relatedness were no longer significant once initial differences in symptoms were accounted for.

While the cross-sectional nature of this study precludes reaching any conclusions regarding causality, results do suggest hypotheses and directions for future research. First, consistent with the initial hypotheses of this study it appears that persons who both accept that they have a mental illness and who accept stigmatizing beliefs about mental illness are at risk for having low self-esteem and expecting less of their futures. These persons, regardless of whether they adhere to treatment, may show little “motivation” to pursue personal or rehabilitation goals,45 having little hope that they can find a satisfying life. This group, substantial in size (roughly a third of our sample), may pose a great challenge to mental health providers, who struggle to encourage these clients to pursue vocational and other goals, when they, the clients themselves, lack hope for the future.

Our findings, consistent with others,1618 also potentially raise a challenge to the view that insight, as traditionally defined, is always desirable for people with schizophrenia. In fact, some with stigmatizing beliefs about mental illness may find accepting their illness burdensome in some ways. This is consistent with the findings suggesting that benefit from psychiatric treatment is related to the meanings persons assign to both their illness and the treatment itself.4648 It is also consistent with observations that well-being for persons who suffer from a wide range of chronic medical illnesses is a function of the degree to which they experience a balance among bodily concerns or symptoms, the sense of coherence of their personal narrative or biography, and conceptions they have formed about the nature of their identity.4951

With replication, our findings may have several clinical implications. First, it may be useful to consider interventions that decrease internalized stigma. Warner,52 for instance, has suggested that it is just as important for interventions to assist in developing a sense of mastery as it is to help enhance insight. This is consistent with a recent intensive case study that suggested that as a person with schizophrenia recovered, he first evolved a greater sense of personal agency before developing a more complex grasp of his illness .53 It is also consistent with a study using a different sample that suggested that hope was more closely tied to sense of agency than illness awareness.54 Perhaps, if dysfunctional beliefs stemming from social stigma impact life in such an enduring manner, tailored interventions could be devised to help persons combat these self-stigmatizing beliefs. Future interventions and research could be directed to help persons with schizophrenia overcome their negative beliefs and find newer and more adaptive ways to think of themselves and their futures, thus allowing for the acceptance of mental illness to have fewer devastating effects. One possibility is for research to study ways to facilitate the efforts of persons with schizophrenia to replace self-stigmatizing beliefs and transform their narratives and experience themselves as active protagonists in their own lives with realistic appraisals of their strengths and deficits.55,56

Of note there may be additional parallels here with earlier studies of differing styles of framing past experience of mental illness as persons recover. Specifically, McGlashan and colleagues5759 have suggested the existence of a continuum of recovery styles. On one end of their continuum lies “integration,” which is characterized by patients showing interest in their psychotic experiences, appearing eager to discuss and learn more about them and to gain a perspective of them. On the other end of the continuum is “sealing over,” characterized by patients’ denial of the existence and/or severity of their illnesses, expectations to return rapidly to normal functioning, and poor ability to recall or describe the phase of acute psychosis. Perhaps these findings coupled with the results of this study point to the reality that, for some, forgetting or recasting the past in such a way as to deny previous difficulties may be adaptive. As a corollary, it may also be that forcing or urging persons who have sealed over to do otherwise may not be helpful, and research that more fully explores what meets their needs is needed.

Importantly, there are several limitations to the study. Given its cross-sectional nature, no conclusions can be drawn regarding causality and alternative explanations of the findings cannot be ruled out. For instance, it is possible that having less hope and self-esteem makes persons more vulnerable to stigma or that acceptance of stigma and low self-esteem is the product of other biological or sociocultural variables not measured here. Generalization of findings is also limited by sample composition. Participants were mostly men in their 40s, all of whom were involved in treatment. It may well be that a different relationship exists among insight, internalized stigma, hope, and self-esteem among younger persons with schizophrenia, in a predominantly female sample, or among persons who decline treatment. Thus, more research that involves collecting data at multiple time points with broader samples is necessary. We also did not assess the nature of stigmatizing experiences. More “fine-grained” assessments of stigma including appraisals of the nature of stigmatizing experiences are necessary to replicate and confirm the importance of the findings noted here.


1. Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr Bull. 1991;17:113–132. [PubMed]
2. David AS. Insight and psychosis. Br J Psychiatry. 1990;156:798–805. [PubMed]
3. Bartko G, Herczeg I, Zador G. Clinical symptomatology and drug compliance in schizophrenia. Acta Psychiatr Scand. 1988;77:74–76. [PubMed]
4. Cuffel BJ, Alford J, Fischer EP, Owen RR. Awareness of illness in schizophrenia and outpatient treatment compliance. J Nerv Ment Dis. 1996;184:653–659. [PubMed]
5. Schwartz RC. The relationship between insight, illness and treatment outcome in schizophrenia. Psychiatric Q. 1998;69:1–22. [PubMed]
6. Francis JL, Penn DL. The relationship between insight and social skill in persons with severe mental illness. J Nerv Ment Dis. 2001;189:822–829. [PubMed]
7. Lysaker PH, Bell MD, Bryson GJ, Kaplan EZ. Psychosocial function and insight in schizophrenia. J Nerv Ment Dis. 1998;186:432–436. [PubMed]
8. Olfson M, Marcus SC, Wilk J, West JC. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatr Serv. 2006;57:205–211. [PubMed]
9. Lysaker PH, Bryson GJ, Bell MD. Insight and work performance in schizophrenia. J Nerv Ment Dis. 2002;190:142–146. [PubMed]
10. Frank A, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia. Arch Gen Psychiatry. 1990;47:228–236. [PubMed]
11. Amador XF, Strauss DH, Yale SA, et al. Awareness of illness in schizophrenia. Arch Gen Psychiatry. 1994;51:826–836. [PubMed]
12. Dixon M, King S, Steiger H. The contribution of depression and denial towards understanding the unawareness of symptoms in schizophrenic out-patients. Br J Medical Psychol. 1998;71:85–97. [PubMed]
13. Mintz AR, Dobson KS, Romney DM. Insight in schizophrenia: a meta-analysis. Schizophr Res. 2003;61:75–88. [PubMed]
14. Thompson EH. Variations in the self-concept of young adult chronic patients: Chronicity reconsidered. Hosp Community Psychiatry. 1988;39:771–775. [PubMed]
15. Warner R, Taylor D, Powers M, Hyman R. Acceptance of the mental illness label by psychotic patients: effects on functioning. Am J Orthopsychiatry. 1989;59:389–409. [PubMed]
16. Hasson-Ohayon I, Kravetz S, Roe D, Weiser M. Insight into severe mental illness, perceived control over the illness, and quality of life. Compr Psychiatry. 2006;194(7):538–42.
17. Kravetz S, Faust M, David M. Accepting the mental illness label, perceived control over the illness, and quality of life. Psychiatr Rehabil J. 2000;23:323–332.
18. Moore O, Cassidy E, Carr A, O'Callaghan E. Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur Psychiatry. 1999;14:264–269. [PubMed]
19. O'Mahony PD. Psychiatric patient denial of mental illness as a normal process. Br J Med Psychol. 1982;55:109–118. [PubMed]
20. Pyne JM, Bean D, Sullivan G. Characteristics of patients with schizophrenia who do not believe they are mentally ill. J Nerv Ment Dis. 2001;189:146–153. [PubMed]
21. Schwartz RC. Self-awareness in schizophrenia: its relationship to depressive symptomatology and broad psychiatric impairments. J Nerv Ment Dis. 2001;189:401–403. [PubMed]
22. Roe D, Kravetz S. Different ways of being aware of and acknowledging a psychiatric disability. A multifunctional narrative approach to insight into mental disorder. J Nerv Ment Dis. 2003;191:417–424. [PubMed]
23. Lally SJ. Does being in here mean there is something wrong with me? Schizophr Bull. 1989;15:253–265. [PubMed]
24. Williams CC, Collins A. Factors associated with insight among outpatients with serious mental illness. Psychiatr Serv. 2002;53:96–98. [PubMed]
25. McCay EA, Seeman MV. A scale to measure the impact of a schizophrenic illness on an individual's self-concept. Arch Psychiatr Nurs. 1998;12:41–49. [PubMed]
26. Ritsher JB, Phelan JC. Internalized stigma predicts erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129:257–265. [PubMed]
27. Link BG, Frances TC, Struening E, Shrout PE, Dohrenwend BP. A modified labeling theory approach to mental disorders: an empirical assessment. Am Sociol Rev. 1989;54:400–423.
28. Roe D. Progressing from patienthood to personhood across the multidimensional outcomes in schizophrenia and related disorders. J Nerv Ment Dis. 2001;189:691–699. [PubMed]
29. Yanos PT, Moos RH. Determinants of functioning and well-being in schizophrenia: an integrated model. Clin Psychol Rev. In press. [PMC free article] [PubMed]
30. Lysaker PH, Campbell K, Johannesen JK. Hope, awareness of illness, and coping in schizophrenia spectrum disorders. J Nerv Ment Dis. 2005;193:287–292. [PubMed]
31. Bradshaw W, Brekke JS. Subjective experience in schizophrenia: factors influencing self-esteem, satisfaction with life, and subjective distress. Am J Orthopsychiatry. 1999;69:254–260. [PubMed]
32. Markowitz FE. The effects of stigma on the psychological well-being and life satisfaction of persons with mental illness. J Health Soc Behav. 1998;39:335–347. [PubMed]
33. Roe D. A prospective study on the relationship between self-esteem and functioning during the first year after being hospitalized for psychosis. J Nerv Ment Dis. 2003;191:45–49. [PubMed]
34. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM IV. New York, NY: Biometrics Research; 1994.
35. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276. [PubMed]
36. Bell MD, Lysaker PH, Beam-Goulet JL, Milstein RM, Lindenmayer JP. Five-component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Res. 1994;52:295–303. [PubMed]
37. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for assessing the schizophrenic deficit syndrome. Schizophr Bull. 1984;10:388–396. [PubMed]
38. Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121:31–49. [PubMed]
39. O'Brien EJ, Epstein S. MSEI: The Multidimensional Self-esteem Inventory Professional Manual. Lutz, Fla: Psychological Assessment Resources, Inc; 1998.
40. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42:861–865. [PubMed]
41. Haatainen KM, Tanskanen A, Kylma J, et al. Life events are important in the course of hopelessness-a 2-year follow-up study in a general population. Soc Psychiatry Psychiatr Epidemiol. 2003;38:436–441. [PubMed]
42. Carpenter WT, Bartko JJ, Carpenter CL, Strauss JS. Another view of schizophrenia subtypes: a report from the international pilot study of schizophrenia. Arch Gen Psychiatry. 1976;33:508–516. [PubMed]
43. Dillon WR, Goldstein M. Multivariate Analysis: Methods and Applications. New York, NY: John Wiley & Sons; 1984.
44. SPSS . SPSS Base 10.0 User's Guide. Chicago, Ill: SPSS, Inc; 1999.
45. Rusch N, Corrigan PW. Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatr Rehab J. 2002;26:23–33. [PubMed]
46. Deegan PE. The importance of personal medicine: a qualitative study of resilience in people with psychiatric disabilities. Scand J Public Health. 2005;66:29–35. [PubMed]
47. Lacro J, Dunn L, Dolder C. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892–908. [PubMed]
48. Tait L, Birchwood M, Trower P. Predicting engagement with services for psychosis: insight, symptoms and recovery style. Br J Psychiatry. 2003;182:123–128. [PubMed]
49. Albrecht GL, Devleiger PJ. The disability paradox: high quality of life against all odds. Soc Sci Med. 1999;48:977–988. [PubMed]
50. Lambert BL, Street RL, Cegala DJ, Smith DN, Kurtz S, Schofield T. Provider patient communication patient centered care and the mangle of practice. Health Commun. 1997;9:27–43.
51. Lambert BL, Levy NA, Winer J. Keeping the balance and monitoring the self-system: towards a more comprehensive model of medication management in psychiatry. In: Brashers D, Goldsmith D, editors. Communication and the Management of Health and Illness. Mahwah, NJ: Erlbaum;
52. Warner R. Recovery From Schizophrenia: Psychiatry and Political Economy. New York, NY: Routledge; 1994.
53. Lysaker PH, Davis LD, Eckert GJ, Strasburger A, Hunter N, Buck KD. Changes in narrative structure and content in schizophrenia in long term individual psychotherapy: a single case study. Clin Psychol Psychother. 2005;12:406–416.
54. Lysaker PH, Buck KD, Hammoud K, Taylor AC, Roe D. Associations of symptom remission, psychosocial function and hope with qualities of self experience in schizophrenia: comparisons of objective and subjective indicators of recovery. Schizophr Res. 2006;82:241–249. [PubMed]
55. Roe D, Davidson L. Self and narrative in schizophrenia: time to author a new story. J Med Humanit. 2005;31:89–94. [PubMed]
56. Lysaker PH, Lysaker JT. A typology of narrative impoverishment in schizophrenia: implications for understanding the processes of establishing and sustaining dialogue in individual psychotherapy. Couns Psychol Q. 2006;19:57–68.
57. Levy ST, McGlashan TH, Carpenter WT. Integration and sealing-over as revocery styles from acute psychosis: metapsychological and dynamic concepts. J Nerv Ment Dis. 1975;161:307–312. [PubMed]
58. McGlashan TH, Levy ST, Carpenter WT. Integration and sealing over. Clinically distinct recovery styles from schizophrenia. Arch Gen Psychaitry. 1975;32:1269–1272. [PubMed]
59. McGlashan TH, Carpenter WT. Does attitude towards psychosis relate to outcome? Am J Psychiatry. 1981;138:797–801. [PubMed]

Articles from Schizophrenia Bulletin are provided here courtesy of Oxford University Press